BC Innovations | Jan 23, 2018
Distillery Therapeutics

Other; hematology

INDICATION: Poisoning; hematology Mouse studies suggest GnRH/LHRH receptor antagonists could help treat radiation poisoning and chemotherapy-induced myelosuppression. In mice exposed to lethal whole-body radiation, the GnRH/LHRH receptor antagonist Firmagon degarelix increased counts of red blood...
BioCentury | Jun 9, 1997
Strategy

Praecis deal a lesson in matchmaking

Noteworthy Praecis Pharmaceuticals Inc. 's $78 million deal with Synthelabo is a reminder that biotech companies still command leverage when they can bring a partner an advanced product that fits a particular need. The agreement,...
BC Week In Review | Jan 10, 1994
Company News

Atrix deal

Syntex is studying LH-RH antagonists to treat prostatic cancer, uterine fibroids, endometriosis and related diseases. The agreement comes at the end of a period of preliminary research to determine whether Syntex's ganirelix LH-RH antagonist is...
Items per page:
1 - 3 of 3